You Are Here: Home > About Arthritis > Arthritis in the News > Ontario has added Erelzi™ (etanercept) to public drug plan for the treatment of multiple inflammator

Ontario has added Erelzi™ (etanercept) to public drug plan for the treatment of multiple inflammator

Erelzi has been added to public drug plan based on specific criteria in Ontario for the treatment of moderate to severe rheumatoid arthritis and for reducing signs and symptoms of active ankylosing spondylitis.Back to News